 |
 |
This press release has been removed at the request of King Pharmaceuticals, Inc.
For further information, see Important Correction of Drug Information About Embeda (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use C-II
Posted: September 2009
Pentec Health, Inc. initiated a limited, voluntary recall of in-date nutritional prescriptions for renal patients due to lack of sterility assurance...
Including Ambien, Ambien CR, Edluar, and Zolpimist [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public...
The nutraceutical company, Xymogen, (Orlando, FL) and FDA, is notifying consumers and health professionals of the recall of Atriphen, a product sold...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 24th, 2013), Cerner Multum™ (updated Apr 19th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
